{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:13:43Z","timestamp":1788509623535,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xphs.2026.104356","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:24:15Z","timestamp":1780719855000},"page":"104356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a SMEDDS for oral delivery of hydrophilic peptide difelikefalin acetate: Preparation, characterization, and PK\/PD evaluation"],"prefix":"10.1016","volume":"115","author":[{"given":"Congmei","family":"Ming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2026.104356_bib0001","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1021\/acs.jmedchem.7b00318","article-title":"The current state of peptide drug discovery: back to the future","volume":"61","author":"Henninot","year":"2018","journal-title":"J. Med Chem."},{"issue":"3","key":"10.1016\/j.xphs.2026.104356_bib0002","first-page":"155","article-title":"The discovery of insulin: what really happened 80 years ago[J]","volume":"16","author":"Dominguez","year":"2001","journal-title":"Annali Italiani di Medicina Interna"},{"key":"10.1016\/j.xphs.2026.104356_bib0003","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1021\/ie50183a004","article-title":"The preparation of insulin","volume":"17","author":"Scott","year":"1925","journal-title":"Ind. Eng. Chem."},{"issue":"3","key":"10.1016\/j.xphs.2026.104356_bib0004","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3390\/molecules31030419","article-title":"The pharmaceutical industry in 2025: an analysis of FDA drug approvals from the perspective of molecules","volume":"31","author":"de la Torre","year":"2026","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.xphs.2026.104356_bib0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.xphs.2026.104356_bib0006","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s44194-024-00041-w","article-title":"The transformative breakthroughs in GLP-1 research recognized by the 2024 Lasker-DeBakey award","volume":"3","author":"Zhou","year":"2024","journal-title":"Current Medicine"},{"key":"10.1016\/j.xphs.2026.104356_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114322","article-title":"Characterization and impact of peptide physicochemical properties on oral and subcutaneous delivery","volume":"186","author":"Klepach","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.xphs.2026.104356_bib0008","article-title":"Progress and limitations of oral peptide delivery as a potentially transformative therapy","volume":"19","author":"Tran","year":"2022","journal-title":"Expert Opin Drug Deliv"},{"issue":"10","key":"10.1016\/j.xphs.2026.104356_bib0009","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1021\/bm060065f","article-title":"Chitosan graft copolymer nanoparticles for oral protein drug delivery: preparation and characterization","volume":"7","author":"Qian","year":"2006","journal-title":"Biomacromolecules"},{"issue":"23","key":"10.1016\/j.xphs.2026.104356_bib0010","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1016\/j.lfs.2004.05.027","article-title":"The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer","volume":"75","author":"Degim","year":"2004","journal-title":"Life Sci"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2026.104356_bib0011","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijpharm.2016.04.044","article-title":"Impact of lipases on the protective effect of SEDDS for incorporated peptide drugs towards intestinal peptidases","volume":"508","author":"Leonaviciute","year":"2016","journal-title":"Int J Pharm"},{"issue":"40","key":"10.1016\/j.xphs.2026.104356_bib0012","doi-asserted-by":"crossref","first-page":"10479","DOI":"10.1021\/acs.jafc.8b02879","article-title":"Oral Administration of salecan-based hydrogels for controlled insulin delivery","volume":"66","author":"Qi","year":"2018","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.xphs.2026.104356_bib0013","first-page":"238","article-title":"Glucose-responsive complex micelles for self-regulated delivery of insulin with effective protection of insulin and enhanced hypoglycemic activity in vivo","volume":"181","author":"Wu","year":"2019","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"13","key":"10.1016\/j.xphs.2026.104356_bib0014","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1359-6446(05)03489-6","article-title":"Gastrointestinal patch systems for oral drug delivery","volume":"10","author":"Tao","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.xphs.2026.104356_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123680","article-title":"Development and evaluation of C10 and SNAC erodible tablets for gastric delivery of a GIP\/GLP1 peptide in monkeys","volume":"650","author":"Tran","year":"2024","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2026.104356_bib0016","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0016-5085(98)70205-7","article-title":"Adaptation of the human pancreas to inhibition of luminal proteolytic activity","volume":"115","author":"Friess","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xphs.2026.104356_bib0017","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/jps.2600830336","article-title":"Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation","volume":"83","author":"Kovarik","year":"1994","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.xphs.2026.104356_bib0018","first-page":"109","article-title":"In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin","volume":"469","author":"Hintzen","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104356_bib0019","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1023\/A:1020429321350","article-title":"Dissolution and partitioning behavior of hydrophobic ion-paired compounds","volume":"19","author":"Lengsfeld","year":"2002","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.xphs.2026.104356_bib0020","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1166\/jbn.2012.1371","article-title":"The in vitro and in vivo study on self-nanoemulsifying drug delivery system (SNEDDS) based on insulin-phospholipid complex","volume":"8","author":"Zhang","year":"2012","journal-title":"J Biomed Nanotechnol"},{"issue":"2","key":"10.1016\/j.xphs.2026.104356_bib0021","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1021\/acs.molpharmaceut.6b00875","article-title":"Salecan-based pH-sensitive hydrogels for insulin delivery","volume":"14","author":"Qi","year":"2017","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2026.104356_bib0022","series-title":"(difelikefalin) injection, For Intravenous Use [EB\/OL]","first-page":"11","year":"2021"},{"issue":"1","key":"10.1016\/j.xphs.2026.104356_bib0023","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2219869","article-title":"Negatively charged phospholipids doped liposome delivery system for mRNA with high transfection efficiency and low cytotoxicity","volume":"30","author":"Wang","year":"2023","journal-title":"Drug Deliv"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2026.104356_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(97)00204-6","article-title":"The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins","volume":"52","author":"Bernkop-Schn\u00fcrch","year":"1998","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2026.104356_bib0025","first-page":"402","article-title":"Synthetic peptide amides","volume":"7","author":"Schteingart","year":"2008","journal-title":"US Patent"},{"key":"10.1016\/j.xphs.2026.104356_bib0026","article-title":"The effect of pH on 1,2-distearoyllecithin (DSPC) liposome stability","year":"2025","journal-title":"BenchChem"},{"issue":"6","key":"10.1016\/j.xphs.2026.104356_bib0027","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3390\/ph17060802","article-title":"Ceftazidime and usnic acid encapsulated in Chitosan-coated liposomes for oral administration against colorectal cancer-inducing Escherichia coli","volume":"17","author":"Souza","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.xphs.2026.104356_bib0028","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3390\/pharmaceutics15071912","article-title":"Co-encapsulation of curcumin and \u03b1-tocopherol in bicosome systems: physicochemical properties and biological activity","volume":"15","author":"Vergara","year":"2023","journal-title":"Pharmaceutics"},{"issue":"9\u201310","key":"10.1016\/j.xphs.2026.104356_bib0029","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1166\/jnn.2006.454","article-title":"Liposome size analysis by dynamic\/static light scattering upon size exclusion-\/field flow-fractionation","volume":"6","author":"Hupfeld","year":"2006","journal-title":"J Nanosci Nanotechnol"},{"key":"10.1016\/j.xphs.2026.104356_bib0030","first-page":"10","article-title":"Role of cholesterol in modifying the physical and stability properties of liposomes and in vitro release of vitamin B12","volume":"99","author":"Pavlovic","year":"2025","journal-title":"Eng Proc"},{"issue":"3","key":"10.1016\/j.xphs.2026.104356_bib0031","first-page":"269","article-title":"The effects of cholesterol on the release of free lipids and the physical stability of lecithin liposomes","volume":"31","author":"Liu","year":"2000","journal-title":"J Chin Inst Chem Eng"},{"issue":"6","key":"10.1016\/j.xphs.2026.104356_bib0032","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/nano6070125","article-title":"Soft interaction in liposome nanocarriers for therapeutic drug delivery","volume":"6","author":"Lombardo","year":"2016","journal-title":"Nanomaterials"},{"issue":"6","key":"10.1016\/j.xphs.2026.104356_bib0033","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1039\/C7MD00045F","article-title":"Maltodextrin modified liposomes for drug delivery through the blood-brain barrier","volume":"8","author":"Gurturk","year":"2017","journal-title":"Med Chem Commun"},{"key":"10.1016\/j.xphs.2026.104356_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.111372","article-title":"A meta-analysis for assessing the contributions of trypsin and chymotrypsin as the two major endoproteases in protein hydrolysis in fish intestine","volume":"278","author":"Solovyev","year":"2023","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"issue":"9","key":"10.1016\/j.xphs.2026.104356_bib0035","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3390\/antibiotics12091410","article-title":"Assessing the activity under different physico-chemical conditions, digestibility, and innocuity of a GAPDH-related fish antimicrobial peptide and analogs thereof","volume":"12","author":"Cashman-Kadri","year":"2023","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.xphs.2026.104356_bib0036","first-page":"66","article-title":"Subcellular localization and levels of aminopeptidases and dipeptidase in Saccharomyces cerevisiae","volume":"541","author":"Frey","year":"1978","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.xphs.2026.104356_bib0037","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0016-5085(85)80008-1","article-title":"Human intestinal brush border peptidases","volume":"88","author":"Tobey","year":"1985","journal-title":"Gastroenterology"},{"issue":"1\u20133","key":"10.1016\/j.xphs.2026.104356_bib0038","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejphar.2011.10.003","article-title":"Mechanism underlying insulin uptake in alveolar epithelial cell line RLE-6TN","volume":"672","author":"Oda","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104356_bib0039","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejps.2011.04.011","volume":"43","author":"Sun","year":"2011","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2026.104356_bib0040","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1517\/17425247.3.5.685","article-title":"Promoting absorption of drugs in humans using medium-chain fatty acid-based solid dosage forms: GIPET","volume":"3","author":"Leonard","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.xphs.2026.104356_bib0041","article-title":"Oral peptide drug delivery: design of SEDDS providing a protective effect against intestinal membrane-bound enzymes","author":"Postina","year":"2025","journal-title":"Drug Deliv Transl Res"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926002054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926002054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:33:26Z","timestamp":1788507206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926002054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0022354926002054"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104356","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a SMEDDS for oral delivery of hydrophilic peptide difelikefalin acetate: Preparation, characterization, and PK\/PD evaluation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104356"}}